Morgan Stanley upgrades Novo Nordisk, says risks better priced after sell-off

Investing.com Gold reports: Morgan Stanley upgrades Novo Nordisk, says risks better priced after sell-off. This is a premium/paywalled source, so the brief is based on headline and available metadata only.